Details checkedClinical trial listing onlyCheckedregistry

UC Irvine acute tinnitus migraine-medication study

Also known as: Management of Acute Tinnitus With Migraine Medications, Nortriptyline plus topiramate, Verapamil plus paroxetine, NCT06799169

Institution-led study

Primary source

Sponsor / Institution

Institution-led study

Program Type

Therapeutic

Modality

Small Molecule

Stage

Phase 4

Status

Active

Target Gene

—

Route / Mode

Oral combination medications

Confidence

84%

Status Confidence

Status needs checking

Evidence Strength

Needs more support

Last Reviewed

2026-06-10

Geography

United States

Population

adult, tinnitus, migraine, repurposed-drug

Trial IDs

Mechanism

Active-not-recruiting randomized Phase 4 study comparing nortriptyline plus topiramate versus verapamil plus paroxetine for acute tinnitus, framed around migraine-associated tinnitus management.

Indications

Tinnitus

Notes

Promoted as a verified institution-led study. The record should represent the UC Irvine trial, not the four comparator medications as separate commercial tinnitus products.

Evidence & Sources

1 structured sources

clinicaltrials

Supports: canonicalName, aliases, allCompanies, isIndustrySponsored, stage, status, route, indications...

IDs: NCT06799169

Open

Key Events

2025-01-29

UC Irvine acute tinnitus migraine-medication study first posted

2025-10-10

ClinicalTrials.gov posted latest active-not-recruiting update reviewed in this pass

Clinical Trials (1)